Daniel Welper

Daniel Welper currently serves as Executive Director of Safety Surveillance at Ionis Pharmaceuticals, Inc., a position held since April 2024. Previously, Daniel held the role of Senior Director of PV Science and Operations at Taiho Oncology, Inc. from January 2024 to April 2024. Prior to that, Daniel was Senior Director of Clinical Safety and Risk Management at Astex Pharmaceuticals, Inc. from April 2018 to December 2023. Daniel also served as Director of Pharmacovigilance at Sunesis Pharmaceuticals, Inc. from June 2016 to April 2018 and was Associate Director of Global Pharmacovigilance at Santen from January 2010 to June 2016. Daniel's academic credentials include a Master of Science in Drug Discovery and Development from Drexel University College of Medicine, obtained between January 2018 and January 2020, and a Master of Business Administration in Health Services from the University of La Verne, earned from January 2000 to January 2003.